The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia

The Synergism between DHODH Inhibitors and Dipyridamole Leads to Metabolic Lethality in Acute Myeloid Leukemia

Dihydroorotate Dehydrogenase (DHODH) is a key enzyme of the <i>de novo</i> pyrimidine biosynthesis, whose inhibition can induce differentiation and apoptosis in acute myeloid leukemia (AML). DHODH inhibitors had shown promising in vitro and in vivo activity on solid tumors, but their eff...

Full description

Bibliographic Details
Main Authors: Valentina Gaidano, Mohammad Houshmand, Nicoletta Vitale, Giovanna Carrà, Alessandro Morotti, Valerio Tenace, Stefania Rapelli, Stefano Sainas, Agnese Chiara Pippione, Marta Giorgis, Donatella Boschi, Marco Lucio Lolli, Daniela Cilloni, Alessandro Cignetti, Giuseppe Saglio, Paola Circosta
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
DHODH
dipyridamole
acute myeloid leukemia
apoptosis
differentiation
pyrimidine depletion
Online Access:https://www.mdpi.com/2072-6694/13/5/1003

Internet

https://www.mdpi.com/2072-6694/13/5/1003

Similar Items